Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The Role of 3-O-Methyldopa in the Side Effects of L: -dopa.

The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Abstract Text:

    eun-sook y leeEun-Sook Y Lee,hongtao chenHongtao Chen,jennifer kingJennifer King,clivel charltonClivel Charlton,eun-sook y leeEun-Sook Y Lee,hongtao chenHongtao Chen,jennifer kingJennifer King,clivel charltonClivel Charlton,

    Long-term treatment of L: -dopa for Parkinson's disease (PD) patients induces adverse effects, including dyskinesia, on-off and wearing-off symptoms. However, the cause of these side effects has not been established to date. In the present study, therefore, 3-O-methyldopa (3-OMD), which is a major metabolite of L: -dopa, was tested to determine whether it plays a role in the aforementioned adverse effects. The effects of 3-OMD on the dopaminergic nervous system in the brain were investigated, by examining behavioral, biochemical, and cellular changes in male Sprague-Dawley rats and catecholamine-producing PC12 neuronal cells. The results revealed that the intracerebroventricular (icv) injection of 1 mumol of 3-OMD impaired locomotor activities by decreasing movement time (MT), total distance (TD), and the number of movement (NM) by 70, 74 and 61%, respectively. The biochemical analysis results showed that a single administration of 1 mumole of 3-OMD decreased the dopamine turnover rate (DOPAC/DA) by 40.0% in the rat striatum. 3-OMD inhibited dopamine transporter and uptake in rat brain striatal membranes and PC12 cells. The subacute administration of 3-OMD (5 days, icv) also significantly impaired the locomotor activities and catecholamine levels. 3-OMD induced cytotoxic effects via oxidative stress and decreased mitochondrial membrane potential in PC12 cells, indicating that 3-OMD can damage neuronal cells. Furthermore, 3-OMD potentiated L: -dopa toxicity and these toxic effects induced by both 3-OMD and L: -dopa were blocked by vitamin E (alpha-tocopherol) in PC12 cells, indicating that 3-OMD may increase the toxic effects of L: -dopa to some extent by oxidative stress. Therefore, the present study reveals that 3-OMD accumulation from long-term L: -dopa treatment may be involved in the adverse effects of L: -dopa therapy. Moreover, L: -dopa treatment might accelerate the progression of PD, at least in part, by 3-OMD.

    The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Publishing Authors By Initials

    es leeES Lee,h chenH Chen,j kingJ King,c charltonC Charlton,es leeES Lee,h chenH Chen,j kingJ King,c charltonC Charlton,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Neurochemical research

    VOLUME: 33

    Page Numbers: 401-11

    Journal Abbreviation: Neurochem. Res.

    ISSN: 0364-3190

    DAY: 24

    MONTH: 08

    YEAR: 2007

    The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7613461

    The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The Role of 3-O-Methyldopa in the Side Effects of L: -dopa. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The Role of 3-O-Methyldopa in the Side Effects of L: -dopa.

    AFFILIATION: Department of Neurobiology and Neurotoxicology, Meharry Medical College, Nashville, TN, 37208, USA, elee@mmc.edu.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Neurochem Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The Role of 3-O-Methyldopa in the Side Effects of L: -dopa Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News